Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Clin Pharmacol. 2011 May 10;52(4):10.1177/0091270011402826. doi: 10.1177/0091270011402826

Table II.

Summary of Final Population Enzyme Maturation Model Pharmacokinetic and Covariate Parameter Estimates for Complete Data Set

Parameter (Unit) Model Parameter
Estimate (%RSE)
CL/F = (CL/F)Std_FF*fSize*fEM(HFF, AgeCL50FF)/fF
 (CL/F)Std_FF (L/h) 23.7a (11.0)
 HFF 2.88 (23.5)
 AgeCL50FF (mo) 10.7 (6.4)
CL/F = (CL/F)Std_FS*fSize*fEM(HFS, AgeCL50FS)/fF
 (CL/F)Std_FS (L/h) 23.7a (11.0)
 HFS 0.82 (37.5)
 AgeCL50FS (mo) 15.1 (20.9)
CL/F = (CL/F)Std_SS*fSize/fF
 (CL/F)Std_SS (L/h) 7.35a (9.3)
V/F = (V/F)Std*fSize/fF
 (V/F)Std (L) 53.3a (7.7)
fSize = (WT/70)Power
 Power for CL/F 0.75 fixed
 Power for V/F 1 fixed
fF(AgeF50)
 AgeF50 (mo) 1.18 (37.5)
Ka 3 fixed
Residual variability
 Proportional (CV%) 13.4
a

(CL/F)Std and (V/F)Std estimates in the final model are 70-kg body weight–normalized values. %RSE is percentage relative standard error. fSize, fEM, and fF are defined in the Methods section.